vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $382.2M, roughly 1.1× LifeStance Health Group, Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -15.5%, a 18.6% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -11.6%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $-137.5M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
EPC vs LFST — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $382.2M |
| Net Profit | $-65.7M | $11.7M |
| Gross Margin | 38.1% | — |
| Operating Margin | -4.5% | 4.7% |
| Net Margin | -15.5% | 3.1% |
| Revenue YoY | -11.6% | 17.4% |
| Net Profit YoY | -3028.6% | 264.1% |
| EPS (diluted) | $-1.41 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $382.2M | ||
| Q3 25 | $600.5M | $363.8M | ||
| Q2 25 | $627.2M | $345.3M | ||
| Q1 25 | $580.7M | $333.0M | ||
| Q4 24 | $415.1M | $325.5M | ||
| Q3 24 | $517.6M | $312.7M | ||
| Q2 24 | $647.8M | $312.3M | ||
| Q1 24 | $599.4M | $300.4M |
| Q4 25 | $-65.7M | $11.7M | ||
| Q3 25 | $-30.6M | $1.1M | ||
| Q2 25 | $29.1M | $-3.8M | ||
| Q1 25 | $29.0M | $709.0K | ||
| Q4 24 | $-2.1M | $-7.1M | ||
| Q3 24 | $8.8M | $-6.0M | ||
| Q2 24 | $49.0M | $-23.3M | ||
| Q1 24 | $36.0M | $-21.1M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 41.6% | — | ||
| Q3 24 | 41.1% | — | ||
| Q2 24 | 44.3% | — | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | 4.7% | ||
| Q3 25 | -4.2% | 2.0% | ||
| Q2 25 | 8.6% | -0.9% | ||
| Q1 25 | 10.1% | 0.5% | ||
| Q4 24 | 2.2% | 0.3% | ||
| Q3 24 | 3.9% | 0.0% | ||
| Q2 24 | 12.8% | -5.1% | ||
| Q1 24 | 11.7% | -5.6% |
| Q4 25 | -15.5% | 3.1% | ||
| Q3 25 | -5.1% | 0.3% | ||
| Q2 25 | 4.6% | -1.1% | ||
| Q1 25 | 5.0% | 0.2% | ||
| Q4 24 | -0.5% | -2.2% | ||
| Q3 24 | 1.7% | -1.9% | ||
| Q2 24 | 7.6% | -7.5% | ||
| Q1 24 | 6.0% | -7.0% |
| Q4 25 | $-1.41 | — | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.62 | — | ||
| Q1 25 | $0.60 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.18 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $248.6M |
| Total DebtLower is stronger | $1.5B | $282.8M |
| Stockholders' EquityBook value | $1.5B | $1.5B |
| Total Assets | $3.8B | $2.2B |
| Debt / EquityLower = less leverage | 1.03× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | $209.1M | $102.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | $1.5B | $282.8M | ||
| Q3 25 | $1.4B | $284.6M | ||
| Q2 25 | $1.4B | $286.4M | ||
| Q1 25 | $1.4B | $288.2M | ||
| Q4 24 | $1.4B | $290.0M | ||
| Q3 24 | $1.3B | $287.3M | ||
| Q2 24 | $1.3B | $288.0M | ||
| Q1 24 | $1.4B | $288.8M |
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $3.8B | $2.2B | ||
| Q3 25 | $3.8B | $2.1B | ||
| Q2 25 | $3.8B | $2.1B | ||
| Q1 25 | $3.8B | $2.1B | ||
| Q4 24 | $3.7B | $2.1B | ||
| Q3 24 | $3.7B | $2.1B | ||
| Q2 24 | $3.7B | $2.1B | ||
| Q1 24 | $3.8B | $2.1B |
| Q4 25 | 1.03× | 0.19× | ||
| Q3 25 | 0.89× | 0.19× | ||
| Q2 25 | 0.88× | 0.19× | ||
| Q1 25 | 0.95× | 0.20× | ||
| Q4 24 | 0.97× | 0.20× | ||
| Q3 24 | 0.81× | 0.20× | ||
| Q2 24 | 0.82× | 0.20× | ||
| Q1 24 | 0.88× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $57.6M |
| Free Cash FlowOCF − Capex | $-137.5M | $46.6M |
| FCF MarginFCF / Revenue | -32.5% | 12.2% |
| Capex IntensityCapex / Revenue | 2.7% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $57.6M | ||
| Q3 25 | $74.1M | $27.3M | ||
| Q2 25 | $114.8M | $64.4M | ||
| Q1 25 | $45.1M | $-3.1M | ||
| Q4 24 | $-115.6M | $62.3M | ||
| Q3 24 | $-388.3M | $22.7M | ||
| Q2 24 | $101.2M | $44.1M | ||
| Q1 24 | $129.0M | $-21.8M |
| Q4 25 | $-137.5M | $46.6M | ||
| Q3 25 | $46.5M | $17.0M | ||
| Q2 25 | $99.3M | $56.6M | ||
| Q1 25 | $28.0M | $-10.3M | ||
| Q4 24 | $-132.4M | $56.0M | ||
| Q3 24 | $-414.2M | $17.7M | ||
| Q2 24 | $88.6M | $39.0M | ||
| Q1 24 | $117.5M | $-26.9M |
| Q4 25 | -32.5% | 12.2% | ||
| Q3 25 | 7.7% | 4.7% | ||
| Q2 25 | 15.8% | 16.4% | ||
| Q1 25 | 4.8% | -3.1% | ||
| Q4 24 | -31.9% | 17.2% | ||
| Q3 24 | -80.0% | 5.7% | ||
| Q2 24 | 13.7% | 12.5% | ||
| Q1 24 | 19.6% | -9.0% |
| Q4 25 | 2.7% | 2.9% | ||
| Q3 25 | 4.6% | 2.8% | ||
| Q2 25 | 2.5% | 2.2% | ||
| Q1 25 | 2.9% | 2.2% | ||
| Q4 24 | 4.0% | 1.9% | ||
| Q3 24 | 5.0% | 1.6% | ||
| Q2 24 | 1.9% | 1.6% | ||
| Q1 24 | 1.9% | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | 3.95× | — | ||
| Q1 25 | 1.56× | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | -44.13× | — | ||
| Q2 24 | 2.07× | — | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
LFST
Segment breakdown not available.
